Procyon Advisors, LLC Bio Path Holdings Inc Transaction History

Procyon Advisors, LLC

  • $1.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 22, 2020
SELL
$3.85 - $5.5 $9,625 - $13,750
-2,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.15 - $6.04 $6,225 - $9,060
1,500 Added 150.0%
2,500 $13,000
Q4 2019

Feb 21, 2020
BUY
$6.97 - $12.3 $6,970 - $12,300
1,000 New
1,000 $8,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $6.37M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email